» Articles » PMID: 24451293

Finding the Rules for Successful Drug Optimisation

Overview
Specialty Pharmacology
Date 2014 Jan 24
PMID 24451293
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Drug discovery is a process of multiparameter optimisation, with the objective of finding compounds that achieve multiple, project-specific property criteria. These criteria are often based on the subjective opinion of the project team, but analysis of historical data can help to find the most appropriate profile. Computational 'rule induction' approaches enable an objective analysis of complex data to identify interpretable, multiparameter rules that distinguish compounds with the greatest likelihood of success for a project. Each property criterion highlights the most critical data that enable effective compound prioritisation decisions. We illustrate this with two applications: determining rules for simple, drug-like properties; and exploring experimental target inhibition data to find rules to reduce the risk of toxicity.

Citing Articles

In vitro tools for orally inhaled drug products-state of the art for their application in pharmaceutical research and industry and regulatory challenges.

Metz J, Hittinger M, Lehr C In Vitro Model. 2024; 1(1):29-40.

PMID: 38624975 PMC: 8688684. DOI: 10.1007/s44164-021-00003-8.


ABDpred: Prediction of active antimicrobial compounds using supervised machine learning techniques.

Jana T, Sarkar D, Ganguli D, Mukherjee S, Mandal R, Das S Indian J Med Res. 2024; 159(1):78-90.

PMID: 38345040 PMC: 10954100. DOI: 10.4103/ijmr.ijmr_1832_22.


Pathophysiological Role and Medicinal Chemistry of A Adenosine Receptor Antagonists in Alzheimer's Disease.

Merighi S, Borea P, Varani K, Vincenzi F, Travagli A, Nigro M Molecules. 2022; 27(9).

PMID: 35566035 PMC: 9102440. DOI: 10.3390/molecules27092680.


In silico predictions on the possible mechanism of action of selected bioactive compounds against breast cancer.

Muhammad A, Katsayal B, Forcados G, Malami I, Abubakar I, Kandi A In Silico Pharmacol. 2020; 8(1):4.

PMID: 33194532 PMC: 7652978. DOI: 10.1007/s40203-020-00057-8.


Machine learning guided association of adverse drug reactions with in vitro target-based pharmacology.

Ietswaart R, Arat S, Chen A, Farahmand S, Kim B, DuMouchel W EBioMedicine. 2020; 57:102837.

PMID: 32565027 PMC: 7379147. DOI: 10.1016/j.ebiom.2020.102837.